{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T05:34:30Z","timestamp":1648964070846},"reference-count":56,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10063","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T14:19:53Z","timestamp":1553005193000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum\u2011derived hepatitis C virus can infect human glioblastoma cell line SF268 and activate the PI3K\u2011Akt pathway"],"prefix":"10.3892","author":[{"given":"Guosheng","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Rong","sequence":"additional","affiliation":[{"name":"Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat\u2011sen University, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat\u2011sen University, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat\u2011sen University, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat\u2011sen University, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong\u2011Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"HBVtech, Frederick, MD 20874, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2011Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Human Virology and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat\u2011sen University, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"key":"key20200713232605_b1-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"easloffice@easloffice.eu: EASL recommendations on treatment of hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver. Electronic address","year":"2017","journal-title":"J Hepatol"},{"key":"key20200713232605_b2-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"key20200713232605_b3-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"AASLD\/IDSA HCV Guidance","year":"2015","journal-title":"Hepatology"},{"key":"key20200713232605_b4-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"key20200713232605_b5-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nature04975","article-title":"Structure of the catalytic domain of the hepatitis C virus NS2-3 protease","volume":"442","author":"Lorenz","year":"2006","journal-title":"Nature"},{"key":"key20200713232605_b6-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/s-0031-1297924","article-title":"HCV and HCC: Clinical update and a review of HCC-associated viral mutations in the core gene","volume":"31","author":"Ahmad","year":"2011","journal-title":"Semin Liver Dis"},{"key":"key20200713232605_b7-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jhep.2016.04.031","article-title":"Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study","volume":"65","author":"Vandenbulcke","year":"2016","journal-title":"J Hepatol"},{"key":"key20200713232605_b8-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.27271","article-title":"Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"key20200713232605_b9-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1128\/JVI.01890-08","article-title":"Hepatitis C virus neuroinvasion: Identification of infected cells","volume":"83","author":"Wilkinson","year":"2009","journal-title":"J Virol"},{"key":"key20200713232605_b10-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1128\/JVI.79.14.8742-8749.2005","article-title":"Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: Control of cell survival and viral replication","volume":"79","author":"Mannov\u00e1","year":"2005","journal-title":"J Virol"},{"key":"key20200713232605_b11-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1871528113666140908113841","article-title":"HCV-related central and peripheral nervous system demyelinating disorders","volume":"13","author":"Mariotto","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"key20200713232605_b12-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1128\/JVI.78.11.5867-5874.2004","article-title":"Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C","volume":"78","author":"Pham","year":"2004","journal-title":"J Virol"},{"key":"key20200713232605_b13-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.20518","article-title":"Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C","volume":"41","author":"Radkowski","year":"2005","journal-title":"Hepatology"},{"key":"key20200713232605_b14-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"Letendre","year":"2007","journal-title":"J Infect Dis"},{"key":"key20200713232605_b15-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gut.2005.080267","article-title":"Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment","volume":"55","author":"Weissenborn","year":"2006","journal-title":"Gut"},{"key":"key20200713232605_b16-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J Virol"},{"key":"key20200713232605_b17-mmr-19-05-4441","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12711","article-title":"Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx","volume":"19","author":"Grigorov","year":"2017","journal-title":"Cell Microbiol"},{"key":"key20200713232605_b18-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1128\/JVI.01402-14","article-title":"Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors","volume":"88","author":"Lavie","year":"2014","journal-title":"J Virol"},{"key":"key20200713232605_b19-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1128\/JVI.01818-10","article-title":"Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection","volume":"85","author":"Tong","year":"2011","journal-title":"J Virol"},{"key":"key20200713232605_b20-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"RC114","DOI":"10.1523\/JNEUROSCI.20-23-j0004.2000","article-title":"Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1beta in primary human fetal astrocytes","volume":"20","author":"Duffy","year":"2000","journal-title":"J Neurosci"},{"key":"key20200713232605_b21-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0002-9440(10)64030-8","article-title":"Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain","volume":"158","author":"Husemann","year":"2001","journal-title":"Am J Pathol"},{"key":"key20200713232605_b22-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jvh.12480","article-title":"Serum-derived hepatitis C virus 1a infection of human astrocyte cell line SVG","volume":"23","author":"Rajalakshmy","year":"2016","journal-title":"J Viral Hepat"},{"key":"key20200713232605_b23-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1365-2893.2010.01339.x","article-title":"Hepatitis C virus enters human peripheral neuroblastoma cells-evidence for extra-hepatic cells sustaining hepatitis C virus penetration","volume":"18","author":"B\u00fcrgel","year":"2011","journal-title":"J Viral Hepat"},{"key":"key20200713232605_b24-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1586\/erm.12.30","article-title":"The cellular origin for malignant glioma and prospects for clinical advancements","volume":"12","author":"Zong","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"key20200713232605_b25-mmr-19-05-4441","first-page":"5917470","article-title":"Metformin treatment inhibits motility and invasion of glioblastoma cancer cells","volume":"2018","author":"Al Hassan","year":"2018","journal-title":"Anal Cell Pathol (Amst)"},{"key":"key20200713232605_b26-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/13550280701798980","article-title":"Viral protein synthesis is required for Enterovirus 71 to induce apoptosis in human glioblastoma cells","volume":"14","author":"Shih","year":"2008","journal-title":"J Neurovirol"},{"key":"key20200713232605_b27-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"e1005924","DOI":"10.1371\/journal.pcbi.1005924","article-title":"Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients","volume":"14","author":"Stein","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"key20200713232605_b28-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1038\/emi.2016.99","article-title":"Differential cell line susceptibility to the emerging Zika virus: Implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"key20200713232605_b29-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"e140131","DOI":"10.1371\/journal.pone.0140131","article-title":"Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 expression","volume":"10","author":"Perazzoli","year":"2015","journal-title":"Plos One"},{"key":"key20200713232605_b30-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0006-291X(85)91020-4","article-title":"Epidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431","volume":"132","author":"Westphal","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713232605_b31-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/JCM.01729-12","article-title":"Performance evaluation of the new Roche cobas AmpliPrep\/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA","volume":"51","author":"Pas","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key20200713232605_b32-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"easloffice@easloffice.eu; European Association for the Study of the Liver: EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"European Association for the Study of the Liver. Electronic address","year":"2018","journal-title":"J Hepatol"},{"key":"key20200713232605_b33-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12072-016-9736-3","article-title":"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"key20200713232605_b34-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.21037\/jtd.2018.06.138","article-title":"Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: A cross-sectional study","volume":"10","author":"Huang","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20200713232605_b35-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/ars.2016.6634","article-title":"The essential Role of Drp1 and its regulation by S-nitrosylation of parkin in dopaminergic neurodegeneration: Implications for parkinson's disease","volume":"25","author":"Zhang","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"key20200713232605_b36-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"41922","DOI":"10.1074\/jbc.M112.414789","article-title":"Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry","volume":"287","author":"Liu","year":"2012","journal-title":"J Biol Chem"},{"key":"key20200713232605_b37-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1073\/pnas.1016606108","article-title":"MicroRNA-122 antagonism against hepatitis C virus genotypes 1\u20136 and reduced efficacy by host RNA insertion or mutations in the HCV 5\u2032 UTR","volume":"108","author":"Li","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713232605_b38-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"e12856","DOI":"10.1371\/journal.pone.0012856","article-title":"Hepatitis C virus core protein induces neuroimmune activation and potentiates human immunodeficiency Virus-1 neurotoxicity","volume":"5","author":"Vivithanaporn","year":"2010","journal-title":"PLoS One"},{"key":"key20200713232605_b39-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1086\/526519","article-title":"Molecular and bioinformatic evidence of hepatitis C virus evolution in brain","volume":"197","author":"Fishman","year":"2008","journal-title":"J Infect Dis"},{"key":"key20200713232605_b40-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"10064","DOI":"10.1128\/JVI.76.19.10064-10068.2002","article-title":"Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid","volume":"76","author":"Laskus","year":"2002","journal-title":"J Virol"},{"key":"key20200713232605_b41-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1128\/JVI.76.2.600-608.2002","article-title":"Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication","volume":"76","author":"Radkowski","year":"2002","journal-title":"J Virol"},{"key":"key20200713232605_b42-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/01.wnl.0000489939.73359.c3","article-title":"Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study","volume":"87","author":"Boyd","year":"2016","journal-title":"Neurology"},{"key":"key20200713232605_b43-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1212\/WNL.0000000000002307","article-title":"Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study","volume":"86","author":"Tsai","year":"2016","journal-title":"Neurology"},{"key":"key20200713232605_b44-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jvh.12521","article-title":"Re: Wangensteen et al. of a letter on \u2018Hepatitis C virus infection: A risk factor for Parkinson's disease\u2019","volume":"23","author":"Chen","year":"2016","journal-title":"J Viral Hepat"},{"key":"key20200713232605_b45-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/JVI.01520-07","article-title":"Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses","volume":"82","author":"Sun","year":"2008","journal-title":"J Virol"},{"key":"key20200713232605_b46-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1134\/S0006297917090085","article-title":"Biochemical variations in cytolytic activity of ortho- and paramyxoviruses in human lung tumor cell culture","volume":"82","author":"Zhirnov","year":"2017","journal-title":"Biochemistry (Mosc)"},{"key":"key20200713232605_b47-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fimmu.2017.00246","article-title":"Host genetic background strongly affects pulmonary microRNA expression before and during influenza A virus infection","volume":"8","author":"Preusse","year":"2017","journal-title":"Front Immunol"},{"key":"key20200713232605_b48-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1128\/JVI.02879-15","article-title":"Human cytomegalovirus stimulates the synthesis of select Akt-dependent antiapoptotic proteins during viral entry to promote survival of infected monocytes","volume":"90","author":"Peppenelli","year":"2016","journal-title":"J Virol"},{"key":"key20200713232605_b49-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11010-013-1825-1","article-title":"LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K\/AKT\/mTOR signaling pathway","volume":"385","author":"Chen","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"key20200713232605_b50-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1128\/JVI.02395-12","article-title":"Varicella-zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase\/Akt pathway to regulate cell cycle progression","volume":"87","author":"Liu","year":"2013","journal-title":"J Virol"},{"key":"key20200713232605_b51-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt\/protein kinase B signaling pathway for insulin resistance","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"key":"key20200713232605_b52-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/gut.2010.217976","article-title":"Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy","volume":"60","author":"Bokemeyer","year":"2011","journal-title":"Gut"},{"key":"key20200713232605_b53-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2009.199356","article-title":"Activation of brain macrophages\/microglia cells in hepatitis C infection","volume":"59","author":"Wilkinson","year":"2010","journal-title":"Gut"},{"key":"key20200713232605_b54-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1111\/j.1365-2893.2011.01510.x","article-title":"Cerebral microglial activation in patients with hepatitis C: In vivo evidence of neuroinflammation","volume":"19","author":"Grover","year":"2012","journal-title":"J Viral Hepat"},{"key":"key20200713232605_b55-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jhep.2008.03.022","article-title":"Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study","volume":"49","author":"Forton","year":"2008","journal-title":"J Hepatol"},{"key":"key20200713232605_b56-mmr-19-05-4441","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13365-011-0039-0","article-title":"Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling","volume":"17","author":"Paulino","year":"2011","journal-title":"J Neurovirol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:18:43Z","timestamp":1594685923000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":56,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10063","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]}}}